Stocks and securities in focus
Security | Change (%) | 1w | 1m ▲ | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Immune Pharmaceuticals Inc | -75.000% | - | - | - | - | - | - |
Progen Pharmaceuticals Ltd | 954.550% | - | - | - | - | - | - |
Applied Therapeutics Inc | 2.450% | - | - | - | - | - | - |
Fate Therapeutics Inc. | 1.220% | -18.612% | -34.136% | -29.888% | 13.133% | -94.298% | - |
Indivior plc | -6.150% | -1.105% | -7.158% | 7.572% | 29.522% | 114.371% | 601.961% |
Heron Therapeutics Inc. | 21.840% | -5.499% | -5.362% | 11.624% | 66.369% | -81.747% | - |
Johnson & Johnson | 0.100% | 2.344% | -3.382% | -6.316% | -1.949% | 1.506% | 10.895% |
Immuron | -3.570% | 1.818% | 0.000% | 29.480% | 34.132% | -47.418% | - |
Advanced Medical Solutions Group plc | 0.930% | 2.885% | 0.943% | -21.324% | -9.322% | -35.152% | -42.627% |
AstraZeneca plc | 4.720% | 4.016% | 9.076% | -2.947% | 9.165% | 53.580% | 92.886% |
Boston Scientific | -0.730% | 7.031% | 9.460% | 47.344% | 33.165% | 93.996% | 119.165% |